Analyst firms · Robert W. Baird · MEDP

Robert W. Baird MEDP price target and rating history

Medpace Holdings Inc. (MEDP) · Health Care

Robert W. Baird rates Medpace Holdings Inc. (MEDP) Neutral with a $547 price target, as of its latest action on Jul 8, 2026. It has published 4 rating actions on MEDP since October 2023, including 2 upgrades and 2 downgrades. Across 6 firms with a MEDP price target in the last 12 months, the median target is $518.50. Robert W. Baird's $547 is 5% above that.

Current rating
Neutral
Price target
$547
Median target, all firms
$518.50
Actions on MEDP
4

Robert W. Baird price target on MEDP

$564$427$289202420252026
Robert W. Baird price target on MEDP, each point a stated target, October 2023 to July 2026.

Every Robert W. Baird rating on MEDP

How other firms rate MEDP

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
UBSNeutral$673Sep 30, 2026
Robert W. BairdNeutral$547Jul 8, 2026
JefferiesHold$515Jul 7, 2026
BarclaysEqual Weight$500Mar 6, 2026
RBC Capital MarketsOutperform$522Mar 3, 2026
TD CowenHold$419Feb 18, 2026

Questions about Robert W. Baird and MEDP

What is Robert W. Baird's price target for MEDP?
Robert W. Baird's latest stated price target for Medpace Holdings Inc. (MEDP) is $547, from its action on Jul 8, 2026.
What is Robert W. Baird's rating on MEDP?
Robert W. Baird rates MEDP Neutral, a neutral rating, as of Jul 8, 2026.
When did Robert W. Baird last change its view on MEDP?
On Jul 8, 2026, Robert W. Baird downgrades to Neutral from Outperform, price target $547.
How does Robert W. Baird's MEDP target compare with other analysts?
Across 6 firms with a MEDP price target in the last 12 months, the median target is $518.50. Robert W. Baird's $547 is 5% above that.

More MEDP rating histories

All Robert W. Baird ratingsMEDP news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.